The Medical Retina Center

Filter Your Results

 

News

 

Aflibercept in DME: The Importance of an Intensive Treatment…

Randomized controlled trials of anti-VEGF agents have shown that excellent outcomes can be achieved in patients with dia…

From Trials to Treatment: The Value of Real-Life Evidence in…

Although randomized, controlled trials remain the gold standard for assessing the efficacy of anti-VEGF agents, real-lif…

Professor Alex Hunyor, Professor Jean-François Korobelnik, Professor Paolo Lanzetta

Polypoidal Choroidal Vasculopathy

Gregg Kokame, MD, joins Timothy Murray, MD, MBA, to discuss his talk on polypoidal choroidal vasculopathy. Dr. Kokame di…

Gregg Kokame, MD, Timothy Murray, MD, MBA

Long-term Anti-VEGF Therapy for DME

Charles Wykoff, MD, PhD, discusses his presentation on long-term anti-VEGF therapy for diabetic macular edema. Relying o…

Timothy Murray, MD, MBA, Charles C. Wykoff, MD, PhD

Predicting Response to Anti-VEGF Monotherapy

Pravin Dugel, MD, joins Timothy Murray, MD, MBA, to discuss how best to identify patients with diabetic macular edema wh…

Pravin Dugel, MD, Timothy Murray, MD, MBA

Protocol T 2-Year Data

Tim Murray, MD, MBA, sits down with Tim Murray, MD, MBA, to talk about new findings from the DRCR.net Protocol T study. …

Neil Bressler, MD, Tim Murray, MD

Object Identification with Artificial Vision

In this, a patient blinded by retinitis pigmentosa displays an ability to positively identify and differentiate between …

Word Identification Using Artificial Vision

A patient wearing the Alpha IMS artificial vision system (Retina Implant AG) correctly identifies white block letters ag…

Avastin and PDR

Yusuke Oshima, MD

Dancing Steroid Implant

Carlos Mateo, MD

Ozurdex Removal

Six weeks after placing an Ozurdex implant in a patient with an anterior chamber IOL and multiple previous operations th…

Jonathan L. Prenner, MD

Programmed Necrosis and Neuroprotection in Retinal Diseases

Demetrios Vavvas, MD, PhD, assistant professor of ophthalmology in disease of the Vitreous and Retina at Massachusetts E…

Ivana Kim, MD, Demetrios Vavvas, MD, PhD

Ozurdex Precision Program: Video Guide to Injection Techniqu…

This video Guide demonstrates the complete details of optimal preparation and injection technique for Ozurdex (Allergan,…

Removal of Ozurdex from Anterior Chamber of Pseudophakic Pat…

This pseudophakic patient underwent Ozurdex injection for posterior uveitis several weeks prior to presenting with compl…

Valli Muthappan, MD, Majid Moshirfar MD

Chronic Anti-VEGF Therapy: Are There Systemic Safety Concern…

Pravin Dugel, MD, of Retinal Consultants in Phoenix, Arizona, talks about systemic safety concerns for patients on long-…

Pravin Dugel, MD

Formulating a Differential

Moderator Thomas Albini, MD, of the Uveitis Resource Center, discusses with Rajiv Shah, MD, how uveitis is involved with…

Rajiv Shah, MD, Thomas Albini, MD

Laboratory Testing in Uveitis

Moderator Thomas Albini, MD, of the Uveitis Resource Center, discusses with Steven Yeh, MD, his experience with laborato…

Steven Yeh, MD, Thomas Albini, MD

Genaral approaches to infectious and noninfectious uveitis t…

Moderator Thomas Albini, MD, of the Uveitis Resource Center, discusses the treatment of uveitis with Sunil Srivastava, M…

Sunil Srivastava, MD, Thomas Albini, MD

Steroids for RVO

Baruch Kuppermann, MD, PhD, talks about the role of steroids in treating retinal vein occlusion cases when patients don'…

Baruch D. Kupperman, MD, PhD

Management of Suspected Endogenous Endophthalmitis: Part 2

A proper workup and timely interventions can help to limit vision loss.

Ted Leng, MD

Ozurdex 2.0: The Game Has Changed

Michael Singer, MD, and Joshua Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas demonstrates …

Michael Singer MD

Navigated Grid Laser Treatment After Bevacizumab Failure in …

Retinal Vein Occlusions are second only to Diabetic Retinopathy as the most common retinal vascular disease. Indifferent…

Stefan Dithmar, MD, Mira Ruppenstein, MD, Thomas Ach, MD, Alexandra Hoeh, MD

Phase 3 Study of Macugen in DME

Dr. Marla B. Sultan, global clinical lead for MACUGEN at Pfizer, discusses the results from a Phase 3 study demonstratin…

Speed of Ozurdex Injection

In a vitrectomized eye, Christopher Riemann, MD, captures the injection of an Ozurdex pellet (Allergan, I…

Christopher Riemann MD

Pharmacosurgery with the Intrector

Vitreo-Retinal pharmacosurgery with Intrector is the newest step for intravitreal combination therapy. In this video, Dr…

Frank Koch MD

InVitria: Intravitreal Injection Assistant

The InVitria (Medical Workshop, The Netherlands) is a disposable device for simplifying intravitreal injections and is d…

Arnaldo Gonçalves MD

Biopsy of Retinal Lesions with a Novel Sub-Retinal Aspiratio…

A 48-year old Hispanic male presented with lesions on both fundi. After two sub-tenon Kenalog injections showed no effec…

Michael Singer MD

Ozurdex Pearls and Pitfalls

Dr. Michael Singer demonstrates his technique for intravitreal delivery of dexamethasone via the Ozurdex system (Allerga…

Michael Singer MD

This Month's Supplements

 
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.